How many patents does
Tianjin Institute Of Pharmaceutical Research have?
patents
857
families
553
granted
283
applications
574
CN
783
EP
22
US
19
WO
17
JP
4
KR
3
RoW
9
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Tianjin Institute Of Pharmaceutical Research
Top ten assignees appearing on patents
2009 - 2018
Tianjin Institute Of Pharmaceutical Research
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| phenyl c-glucoside derivative containing deoxyglucose structure, preparation method and … 🛈 | 15 | 2012 |
| phenyl c-glucoside derivatives, preparation methods and uses thereof | 10 | 2010 |
| amide thiazole derivative, preparation method and uses thereof | 9 | 2008 |
| carboxylic acid urat1 inhibitor containing diarylmethane structure, preparation method a… 🛈 | 9 | 2015 |
| glycyrrhetinic acid-30-amide derivatives and the uses thereof | 8 | 2005 |
| thienopyridine ester derivative containing nitrile, preparation method, use and composit… 🛈 | 8 | 2010 |
| cycloastragenol monoglucoside, preparation, pharmaceutical composition and application t… 🛈 | 6 | 2007 |
| a glp-1 analogue, its preparation methods and use thereof | 6 | 2011 |
| glucagon-like peptide-1 analogue monomer and dimer, preparation method therefor and appl… 🛈 | 5 | 2011 |
| pharmaceutical composition comprising candesartan or ester thereof and chlortalidone, an… 🛈 | 4 | 2011 |